Phase III trial of adjuvant 13-cis-retinoic acid and interferon-alpha for patients with aggressive skin squamous cell carcinoma.

被引：0
|
作者：
Brewster, Abenaa M.
Lee, J. Jack
Clayman, Gary
Clifford, John
Reyes, Mary Jo Necesito
Zhou, Xian
Sabichi, Anita
Strom, Sara
Collins, Robert
Meyers, Christina
Lippman, Scott
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
[2] LSU Hlth Sci Ctr, Shreveport, LA USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5659
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma
    Brewster, Abenaa M.
    Lee, J. Jack
    Clayman, Gary L.
    Clifford, John L.
    Reyes, Mary Jo T. Necesito
    Zhou, Xian
    Sabichi, Anita L.
    Strom, Sara S.
    Collins, Robert
    Meyers, Christina A.
    Lippman, Scott M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) : 1974 - 1978
  • [2] Clinical and in vitro response to 13-cis-retinoic acid in interferon-alpha resistant renal cell carcinoma
    Buer, J
    Probst, M
    Duensing, S
    Koditz, H
    Franzke, A
    Dallmann, I
    Ganser, A
    Atzpodien, J
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1997, 12 (03) : 143 - 147
  • [3] Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma
    Motzer, RJ
    Murphy, BA
    Bacik, J
    Schwartz, LH
    Nanus, DM
    Mariani, T
    Loehrer, P
    Wilding, G
    Fairclough, DL
    Cella, D
    Mazumdar, M
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) : 2972 - 2980
  • [4] 13-CIS-RETINOIC ACID PLUS INTERFERON-ALPHA - A PHASE-II CLINICAL-STUDY IN SQUAMOUS-CELL CARCINOMA OF THE LUNG AND THE HEAD AND NECK
    ROTH, AD
    ABELE, R
    ALBERTO, P
    ONCOLOGY, 1994, 51 (01) : 84 - 86
  • [5] 13-CIS-RETINOIC ACID AND INTERFERON ALPHA-2A - EFFECTIVE COMBINATION THERAPY FOR ADVANCED SQUAMOUS-CELL CARCINOMA OF THE SKIN
    LIPPMAN, SM
    PARKINSON, DR
    ITRI, LM
    WEBER, RS
    SCHANTZ, SP
    OTA, DM
    SCHUSTERMAN, MA
    KRAKOFF, IH
    GUTTERMAN, JU
    HONG, WK
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (04) : 235 - 241
  • [6] PHASE-II STUDY OF 13-CIS-RETINOIC ACID PLUS INTERFERON-ALPHA(2A) IN HEAVILY PRETREATED SQUAMOUS CARCINOMA OF THE CERVIX
    HALLUM, AV
    ALBERTS, DS
    LIPPMAN, SM
    INCLAN, L
    SHAMDAS, GJ
    CHILDERS, JM
    SURWIT, EA
    MODIANO, M
    HATCH, KD
    GYNECOLOGIC ONCOLOGY, 1995, 56 (03) : 382 - 386
  • [7] Pilot phase II trial of 13-cis-retinoic acid and interferon-alpha combination therapy for advanced pancreatic adenocarcinoma
    Moore, DF
    Pazdur, R
    Sugarman, S
    Jones, D
    Lippman, SM
    Bready, B
    Abbruzzese, JL
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (06): : 525 - 527
  • [8] 13-cis-retinoic acid and interferon-alpha 2a as palliative therapy of pretreated, recurrent squamous cell carcinoma of the uterine cervix and vulva
    Romisch, M
    Meier, W
    Kimmig, R
    Hepp, H
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1996, 56 (10) : 520 - 524
  • [9] 13-cis-retinoic acid and alpha-interferon in advanced squamous cell cancer of the oesophagus
    Kok, TC
    vanderGaast, A
    Splinter, TAW
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (01) : 165 - 166
  • [10] EFFICACY OF RECOMBINANT ALPHA-INTERFERON-2A AND 13-CIS-RETINOIC ACID IN THE TREATMENT OF SQUAMOUS-CELL CARCINOMA
    TOMA, S
    PALUMBO, R
    VINCENTI, M
    AITINI, E
    PAGANINI, G
    PRONZATO, P
    GRIMALDI, A
    ROSSO, R
    ANNALS OF ONCOLOGY, 1994, 5 (05) : 463 - 465
12345